Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Globalization and Health|July 3, 2024
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and responseTiwadayo Braimoh, Esteban Burrone, Charles Gore, et al.Journal of the International AIDS Society|July 13, 2023
Voluntary licensing of long-acting HIV prevention and treatment regimens: using a proven collaboration- and competition-based mechanism to rapidly expand at-scale, sustainable, quality-assured and affordable supplies in LMICsLobna Gaayeb, Aditi Das, Ike James, et al.MMWR. Morbidity and Mortality Weekly Report|July 20, 2018
Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016Yvan Hutin, Muazzam Nasrullah, Philippa Easterbrook, et al.The Lancet. Public Health|October 28, 2021
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling studySébastien Morin, Hannah Barron Moak, Oliver Bubb-Humfryes, et al.Global Heart|November 5, 2020
NOACs Added to WHO's Essential Medicines List: Recommendations for Future Policy ActionsMariachiara Di Cesare, Jordan D Jarvis, Oana Scarlatescu, et al.The Lancet. Global Health|December 1, 2022
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunitiesSébastien Morin, Giulia Segafredo, Manuele Piccolis, et al.PLOS Global Public Health|July 1, 2024
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countriesShelly Malhotra, Anne-Isabelle Cameron, Dzintars Gotham, et al.Pageof 1